Biodexa Pharmaceuticals Plc (BDRX) News
Track canonical SquawkNews coverage tagged to BDRX, Biodexa Pharmaceuticals Plc. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 8 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
BDRX Holds General Meeting
BDRX holds general meeting
EQUITY | Jul 29, 2026, 08:30 PM UTC
L
BDRX Initiates FAP Support in France
BDRX starts support for FAP patients
EQUITY | Jul 29, 2026, 12:30 PM UTC
L
BDRX Biodexa Pharmaceuticals - files for resale of 2.56M adss by selling shareholders - SEC filing
BDRX Biodexa Pharmaceuticals - files for resale of 2.56M adss by selling shareholders - SEC filing
REGULATION | Jul 15, 2026, 08:13 PM UTC
H
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Liminatus Pharma (NASDAQ: LIMN ) stock increased by 40.9% to $0.16 during Thursday's pre-market session. The market value of their outstanding shares is at $5.8 million. Stablecoin Development (AMEX: SDEV ) stock
EARNINGS | Jul 02, 2026, 12:05 PM UTC
H
Select Premarket Movers
Upside: -AVAV +35% (earnings, guidance) -VWAV +29% (acquires 51% controlling interest in private Israeli aerospace and defense company Meteor Aerospace for ~$20.4M in stock) -SEDG +11% (solar stock strength following FCC
GEOPOLITICS | Jun 30, 2026, 12:26 PM UTC
L
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Abivax (NASDAQ: ABVX ) shares increased by 36.0% to $130.74 during Tuesday's pre-market session. The company's market cap stands at $7.6 billion. Cuprina Holdings (Cayman) (NASDAQ: CUPR ) shares moved upwards by
EQUITY | Jun 30, 2026, 12:05 PM UTC
L
Biodexa Pharmaceuticals shares are trading lower after the company announced the pricing of its $3.5 million offering and concurrent private
Biodexa Pharmaceuticals shares are trading lower after the company announced the pricing of its $3.5 million offering and concurrent private placement of pre-funded warrants and warrants.
EQUITY | Jun 30, 2026, 12:04 PM UTC
L
Biodexa Prices $3.5M Offering And Concurrent Private Placement Of 282,952 Shares At $2.85/ADS.
Biodexa Prices $3.5M Offering And Concurrent Private Placement Of 282,952 Shares At $2.85/ADS.
EQUITY | Jun 30, 2026, 12:03 PM UTC